Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc.verified

MIRM

Price:

$24.07

Market Cap:

$1.13B

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California.[Read more]

Industry

Biotechnology

IPO Date

2019-07-18

Stock Exchange

NASDAQ

Ticker

MIRM

The PE Ratio as of May 2024 (TTM) for Mirum Pharmaceuticals, Inc. (MIRM) is -6.44

According to Mirum Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.44. This represents a change of -34.46% compared to the average of -9.83 of the last 4 quarters.

Mirum Pharmaceuticals, Inc. (MIRM) Historical PE Ratio (quarterly & annually)

How has MIRM PE Ratio performed in the past?

The mean historical PE Ratio of Mirum Pharmaceuticals, Inc. over the last ten years is -5.50. The current -6.44 PE Ratio has changed 11.61% with respect to the historical average. Over the past ten years (40 quarters), MIRM's PE Ratio was at its highest in in the December 2021 quarter at 2.10. The PE Ratio was at its lowest in in the September 2018 quarter at -493.22.

Quarterly (TTM)
Annual

Average

-5.50

Median

-5.31

Minimum

-10.73

Maximum

0

Mirum Pharmaceuticals, Inc. (MIRM) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Mirum Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 51.85%

Maximum Annual PE Ratio = 0

Minimum Annual Increase = -Infinity%

Minimum Annual PE Ratio = -10.73

Quarterly (TTM)
Annual
YearPE RatioChange
2023-7.3951.85%
2022-4.86-15.53%
2021-5.7634.88%
2020-4.27-60.20%
2019-10.73-Infinity%

Mirum Pharmaceuticals, Inc. (MIRM) Average PE Ratio

How has MIRM PE Ratio performed in the past?

The current PE Ratio of Mirum Pharmaceuticals, Inc. (MIRM) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-6.00

5-year avg

-6.60

10-year avg

-5.50

Mirum Pharmaceuticals, Inc. (MIRM) PE Ratio vs. Peers

How is MIRM’s PE Ratio compared to its peers?

Mirum Pharmaceuticals, Inc.’s PE Ratio is greater than Immunocore Holdings plc (-33.19), greater than Larimar Therapeutics, Inc. (-8.77), less than KalVista Pharmaceuticals, Inc. (-3.39), less than Lyra Therapeutics, Inc. (-0.36), less than Terns Pharmaceuticals, Inc. (-4.82), less than Amylyx Pharmaceuticals, Inc. (-1.75), less than Acumen Pharmaceuticals, Inc. (-3.90), less than Inozyme Pharma, Inc. (-3.68), less than X4 Pharmaceuticals, Inc. (-1.44), greater than Day One Biopharmaceuticals, Inc. (-6.71), greater than MoonLake Immunotherapeutics (-61.21), greater than Apellis Pharmaceuticals, Inc. (-12.17), greater than Blueprint Medicines Corporation (-22.42), greater than Cerevel Therapeutics Holdings, Inc. (-16.60), less than Arcutis Biotherapeutics, Inc. (-4.70), greater than Icosavax, Inc. (-8.27), greater than VectivBio Holding AG (-7.94),

Build a custom stock screener for Mirum Pharmaceuticals, Inc. (MIRM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mirum Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mirum Pharmaceuticals, Inc. (MIRM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mirum Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Mirum Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for Mirum Pharmaceuticals, Inc. (MIRM)?

What is the highest PE Ratio for Mirum Pharmaceuticals, Inc. (MIRM)?

What is the 3-year average PE Ratio for Mirum Pharmaceuticals, Inc. (MIRM)?

What is the 5-year average PE Ratio for Mirum Pharmaceuticals, Inc. (MIRM)?

How does the current PE Ratio for Mirum Pharmaceuticals, Inc. (MIRM) compare to its historical average?